Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 20, 2017

Primary Completion Date

September 9, 2024

Study Completion Date

September 9, 2024

Conditions
GlioblastomaGliosarcoma
Interventions
RADIATION

Dose-Escalated Radiation Therapy

Undergo sMRI-guided radiation therapy, dose painted to maximum of 75 Gy over six weeks

PROCEDURE

Spectroscopic Magnetic Resonance Imaging

Patients will undergo sMRI scans within a 14 day window prior to starting treatment

DRUG

Temozolomide

Given PO

Trial Locations (3)

21287

Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore

30322

Emory University/Winship Cancer Institute, Atlanta

33136

University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami

All Listed Sponsors
collaborator

Johns Hopkins University

OTHER

collaborator

University of Miami

OTHER

collaborator

National Cancer Institute (NCI)

NIH

collaborator

National Institutes of Health (NIH)

NIH

lead

Emory University

OTHER

NCT03137888 - Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma | Biotech Hunter | Biotech Hunter